| 前收市價 | 18.49 |
| 開市 | 18.51 |
| 買盤 | 18.70 x 100 |
| 賣出價 | 18.85 x 200 |
| 今日波幅 | 18.51 - 18.89 |
| 52 週波幅 | 13.82 - 24.21 |
| 成交量 | |
| 平均成交量 | 615,119 |
| 市值 | 1.701B |
| Beta 值 (5 年，每月) | 1.98 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.18 |
| 業績公佈日 | 2024年5月01日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 23.91 |
ZacksMyriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.
ZacksHere's Why You Should Retain Myriad Genetics (MYGN) Stock Now
Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.
ZacksNovavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
